Why the Cold Pain Therapy is a Growing Payer Opportunity?
Cold
pain therapy is a therapeutic application of cold, used in
the treatment of acute soft tissue injuries and to reduce the pain in
post-operative condition in orthopedic surgeries, treatment of benign
and malignant lesions, and in pain management. Cryotherapy can be
applied topically (on the skin surface), surgically or
percutaneously. This can also be used to treat various skin
conditions such as oral mucositis and tumors in the liver, kidney,
bones, breasts and lungs, skin tumors, skin tags, pre-cancerous skin
moles, and injuries.
Cryosurgery procedure
involves use of extreme cold, produced with help of liquid nitrogen
(or argon gas) to destroy abnormal tissues. According to the National
Cancer Institute (NCI), cryosurgery is used for treatment of several
types of cancers and some non-cancerous conditions. It is reported to
be effective for treatment in early stage skin cancer,
retinoblastoma, actinic keratosis, and cervical intraepithelial
neoplasia. According to a study published in Journal of the National
Cancer Institute, in October 2017, it was observed that cryotherapy
was effective in controlling the side effects of chemotherapy induced
peripheral neuropathy.
Recent developments in the cold pain therapy
market:
In July 2017, CSA
Medical, Inc. received FDA clearance to expand truFreeze catheter
offering to include Rapid AV Spray Kit. truFreeze system is used in
cryosurgical procedures for application in gynecology, dermatology,
general surgery, and in the removal of malignant lesions. Moreover,
the addition of rapid AV Spray kit with truFreeze catheter is
expected to reduce the surgical time thereby, reducing overall
patient treatment time.
In January 2017,
PENTAX Medical — a company engaged in manufacturing, development
and R&D activities in endoscopic product and services —
acquired the C2 Therapeutics. C2 Therapeutics manufactures C2
CryoBalloon Ablation System for endoscopic ablation of tissue.
Moreover, the acquisition enabled PENTAX Medial to strengthen its
therapeutic endoscopy products and service portfolio.
Key players in the
cold pain therapy market:
Some of the key
players in the cold pain therapy market are CryoConcepts LP, Metrum
Cryoflex, Brymill Cryogenic Systems, Mectronic Mediccale S.r.l.,
Sanarus, Wallach Surgical Devices, Zimmer MedizinSystems,
CooperSurgical Inc., CSA Medical, Inc., Cortex Technology, Erbe
Elektromedizin, GmbH, Special Medical Technology Co., Ltd, Medtronic
plc, Galil Medical, Inc., and PHYSIOMED AG.
Request For
Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1162
Cold Pain Therapy Market Taxonomy:
On the basis of product, cold pain therapy
market segmented into:
• OTC-based
products
◦
Pharmaceuticals
▪ Gels,
ointment and creams
▪
Patches
▪ Spray
and foams
▪
Roll-ons
◦ Medical
devices
▪ Cold
packs
▪
Cooling pads, wraps and pads
◦
Prescription-based products
▪
Motorized cryotherapy devices
▪
Non-motorized cryotherapy devices
On the basis of therapy type, cold pain therapy
market segmented into:
• Cryosurgery
• Icepack
therapy
• Chamber
therapy
On the basis of device type, cold pain therapy
market segmented into:
• Spray cryogun
• Dipstick
applicator
• Cryoprobe
• Other devices
On the basis of application, cold pain therapy
market segmented into:
• Dermatology
• Oncology
•
Musculoskeletal disorder
• Pain
management
• Sport medicine
• Physical
therapy
• Ophthalmology
• Post-operative
• Post-trauma
On the basis of distribution channel, cold pain
therapy market segmented into:
• Online
pharmacies
• Retail
pharmacies
• Hospital
pharmacies
About Coherent Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments
Post a Comment